Type 1 Diabetes (T1DM) Clinical Study Details
Living with Type 1 Diabetes? Join our clinical trial exploring an investigational treatment aimed at improving blood sugar control and daily management. Expert care and no-cost participation included.
Apply To This Study Here
Please enter your name, a valid phone number, and a valid email address where you can be contacted.
Children, teens, and young adults aged 1 to 25 years who have recently been diagnosed with Stage 3 Type 1 Diabetes (T1D) may be eligible.
Participants must begin the study treatment within 8 weeks of diagnosis. This may be extended to 12 weeks if a live vaccine is required before starting the study.
You’ll need to test positive for at least one T1D autoantibody (such as GAD-65, IA-2, ZnT8, insulin, or ICA) and have a C-peptide level of at least 0.2 nmol/L (any detectable level for children under 3).
Yes. Female participants who could become pregnant must use highly effective birth control and test negative for pregnancy before starting. Breastfeeding must also be paused during and for 20 days after the last study dose.
Yes, if you’re under 18, your parent or legally authorized representative must sign a consent form, and you may also need to give your assent to participate.
Participants (or their caregivers) must be willing to follow all study instructions, attend visits, and complete required testing throughout the trial.
Benefits of participating in this study
There are multiple ways you can benefit from joining us in this study. Here are some of them.
Study-related visits, evaluations, and close health monitoring are provided at no cost to participants.
Study visits include complimentary meals and transportation assistance for your appointment day.
Your participation helps researchers better understand medical conditions in a way that may benefit others, including friends, family, and future generations.